Register or Sign in to Save this opportunity, or Send an Inquiry.
Subtype Selective Phosphodiesterase 4 (PDE4) Inhibitors for the Treatment of Chronic Obstructive Pulmonary Diesease
Health Technologies at Strathclyde United Kingdom flag United Kingdom
Abstract ID:
Using a novel screening approach, researchers at Strathclyde have identified subtype selective PDE4 inhibitors.
Send an Inquiry
RE:
Participants
You

Background


Chronic Obstructive Pulmonary Disease (COPD)

GO PREMIUM TO GET PATENT INFORMATION
Type of Business Relationship Sought

Patent applications will be filed upon identification of strong lead candidates. Funding will then be sought for formation of a University of Strathclyde spin-out company to create additional value through identification and profiling of preclinical drug candidates for partnership or sale.

FEATURED
Last Updated Oct 2014
Technology Type
Phase of Development EARLY STAGE
UNIVERSITY

Opportunity Contact